New insights could help block the path of cancer 'super-highways'

October 28, 2019

A key mechanism controlling tissue structure, which could help identify drugs that make it harder for cancer cells to spread, has been identified by researchers at the Francis Crick Institute.

The two studies, published in Nature Materials and PLOS Computational Biology, explain the mechanism that causes changes in the structure of tissues. Using experimental and computational biology, the studies identified how collisions between cells help to create different tissue structures. Some of these structures help cancer spread and the authors also found drugs that inhibit this process.

All tissues in the body contain a scaffold of proteins that maintain their structure. This scaffold degrades as people age, leading to signs of aging such as wrinkles.

Cancerous cells can corrupt the shape of the scaffold to create a tissue structure with pathways that lead away from the tumour and into the surrounding tissue. The cancerous cells take advantage of these super-highways by moving along them to spread into new areas.

However, while it is known that these super-highways are linked to cancer progression, there is little understanding about the mechanisms that control the formation of these tissue structures.

"These super-highways provide roads for cancer cells to travel out of tumours and spread more widely in the tissue, having potentially disastrous consequences for the patient," says Danielle Park, research scientist in the Crick's Tumour Cell Biology Laboratory. "By understanding more about how this type of structure is formed, we can then look at finding ways to stop it and impose a road block on the spread of cancer cells."

By combining insights from laboratory experiments with results from a new computer model which the team developed, the researchers discovered how a tissue scaffold's shape is affected by how it interacts with specialist cells which help to build the scaffold, known as fibroblasts.

"Our computer model draws inspiration from how birds and fish, the fibroblasts in our case, move closely together in flocks or schools, despite being in very large groups," says Esther Wershof, a PhD student in the Biomolecular Modelling Laboratory at the Crick. "With this model, it's much easier to study the relationship between cells and the scaffold than if we could only watch it in real-life."

Further research found that a key factor in the formation of tissue with super-highways is how the fibroblasts act when they collide with each other. By identifying a protein (TFAP2C) that regulates these collisions, the researchers could then look for drugs that inhibit this protein and, in turn, disrupt the creation of super-highways and the spread of cancer cells. Using existing datasets and experiments in the laboratory, the study successfully identified five drugs that affected the formation of super-highways in the tissue.

"This work is a great example of insights that can be uncovered when experimental and computer biologists collaborate. By working together, using a range of techniques and bringing different expertise to the table, we can reach new understandings about how the body works and how we can better treat disease," said Paul Bates, group leader of the Biomolecular Modelling Laboratory at the Crick.
-end-


The Francis Crick Institute

Related Cancer Cells Articles from Brightsurf:

Cancer researchers train white blood cells to attacks tumor cells
Scientists at the National Center for Tumor Diseases Dresden (NCT/UCC) and Dresden University Medicine, together with an international team of researchers, were able to demonstrate that certain white blood cells, so-called neutrophil granulocytes, can potentially - after completing a special training program -- be utilized for the treatment of tumors.

New way to target some rapidly dividing cancer cells, leaving healthy cells unharmed
Scientists at Johns Hopkins Medicine and the University of Oxford say they have found a new way to kill some multiplying human breast cancer cells by selectively attacking the core of their cell division machinery.

Breast cancer cells use message-carrying vesicles to send oncogenic stimuli to normal cells
According to a Wistar study, breast cancer cells starved for oxygen send out messages that induce oncogenic changes in surrounding normal epithelial cells.

Breast cancer cells turn killer immune cells into allies
Researchers at Johns Hopkins University School of Medicine have discovered that breast cancer cells can alter the function of immune cells known as Natural killer (NK) cells so that instead of killing the cancer cells, they facilitate their spread to other parts of the body.

Breast cancer cells can reprogram immune cells to assist in metastasis
Johns Hopkins Kimmel Cancer Center investigators report they have uncovered a new mechanism by which invasive breast cancer cells evade the immune system to metastasize, or spread, to other areas of the body.

Engineered immune cells recognize, attack human and mouse solid-tumor cancer cells
CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma and leukemia.

Drug that keeps surface receptors on cancer cells makes them more visible to immune cells
A drug that is already clinically available for the treatment of nausea and psychosis, called prochlorperazine (PCZ), inhibits the internalization of receptors on the surface of tumor cells, thereby increasing the ability of anticancer antibodies to bind to the receptors and mount more effective immune responses.

Engineered bone marrow cells slow growth of prostate and pancreatic cancer cells
In experiments with mice, researchers at the Johns Hopkins Kimmel Cancer Center say they have slowed the growth of transplanted human prostate and pancreatic cancer cells by introducing bone marrow cells with a specific gene deletion to induce a novel immune response.

First phase i clinical trial of CRISPR-edited cells for cancer shows cells safe and durable
Following the first US test of CRISPR gene editing in patients with advanced cancer, researchers report these patients experienced no negative side effects and that the engineered T cells persisted in their bodies -- for months.

Zika virus' key into brain cells ID'd, leveraged to block infection and kill cancer cells
Two different UC San Diego research teams identified the same molecule -- αvβ5 integrin -- as Zika virus' key to brain cell entry.

Read More: Cancer Cells News and Cancer Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.